0001209191-23-005476.txt : 20230130 0001209191-23-005476.hdr.sgml : 20230130 20230130162218 ACCESSION NUMBER: 0001209191-23-005476 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221125 FILED AS OF DATE: 20230130 DATE AS OF CHANGE: 20230130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kung Winston CENTRAL INDEX KEY: 0001666963 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39539 FILM NUMBER: 23568077 MAIL ADDRESS: STREET 1: C/O PMV PHARMACEUTICALS, INC. STREET 2: 8 CLARKE DRIVE, SUITE 3 CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001699382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463218129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 642-6664 MAIL ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-25 0 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001666963 Kung Winston C/O PMV PHARMACEUTICALS, INC. ONE RESEARCH WAY PRINCETON NJ 08540 0 1 0 0 COO, CFO Common Stock 2022-11-25 5 G 0 E 2560 0.00 D 10600 D The reported shares were acquired under the Issuer's stock purchase plan on November 20, 2022. /s/ Winston Kung 2022-01-30